CEFPOVAC CV SYP WFI

CEFPOVAC CV SYP WFI is a combination antibiotic suspension containing Cefpodoxime Proxetil and Clavulanic Acid, formulated with sterile Water for Injection (WFI) to ensure purity and effectiveness. This suspension is used to treat a variety of bacterial infections by inhibiting bacterial growth and overcoming beta-lactamase resistance.

Key Features:

• Composition: Cefpodoxime Proxetil + Clavulanic Acid in oral suspension form

• Broad-spectrum antibiotic effective against Gram-positive and Gram-negative bacteria

• Clavulanic Acid enhances Cefpodoxime’s effectiveness by inhibiting beta-lactamase enzymes

• Convenient oral suspension, suitable for pediatric and adult patients

Indications:

• Respiratory tract infections (bronchitis, pneumonia)

• Urinary tract infections

• Skin and soft tissue infections

• Ear, nose, and throat infections (sinusitis, otitis media)